Complete Round 1 data (baseline and 12‐month follow‐up) for HPV FOCAL, a randomized
trial establishing the efficacy of HPV DNA testing with cytology triage as a primary screen for …

BACKGROUND: The additional sensitivity of HPV testing compared with cytology could
permit extended cervical screening intervals. We wished to determine, through a further …

Background: Round 1 data of human papillomavirus (HPV) FOCAL, a three-arm,
randomised trial, which aims to establish the efficacy of HPV DNA testing as a primary …

We conducted a prospective randomized controlled trial with two screening rounds to
evaluate the effectiveness of combining HPV testing with liquid‐based cytology (LBC) as a …

Background In the first recruitment phase of a randomized trial of cervical cancer screening
methods (New Technologies for Cervical Cancer Screening [NTCC] study), we compared …

Objective The purpose of this study was to evaluate the feasibility and effectiveness of Viral
Testing Alone with Pap (Papanicolaou) Triage for Screening Cervical Cancer in Routine …

Background Primary cervical screening with both human papillomavirus (HPV) DNA testing
and cytological examination of cervical cells with a Pap test (cytology) has been evaluated in …

Objectives ATHENA evaluated the cobas HPV Test as the primary screen for cervical cancer
in women≥ 25 years. This reports the 3-year end-of-study results comparing the …

Human‐papillomavirus (HPV) DNA testing has been proposed as an alternative to primary
cervical cancer screening using cytological testing. Review of the evidence shows that …

Background: Although testing for human papillomavirus (HPV) has higher sensitivity and
lower specificity than cytology alone for detecting cervical intraepithelial neoplasia (CIN) …